Critical Diagnostics Release: ST2 Values Predict Mortality and Morbidity in Heart Failure Patients: Results from the AstraZeneca AB-sponsored CORONA Study

Published: Feb 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics today announced publication in the European Journal of Heart Failure of an analysis describing the prognostic power of ST2 in the CORONA study, where the investigators assessed the association between ST2 and cause-specific outcomes in 1449 clinically stable, older heart failure patients with ischemic etiology.

Back to news